Poolbeg Pharma’s Jeremy Skillington talks to Proactive London after signing a deal with CytoReason, a leading artificial intelligence (AI) to provide AI analysis of Poolbeg’s influenza disease progression data derived from human challenge study samples.
Watch the video here.
![[Virgin Hyperloop One in NBCDFW] Virgin Hyperloop One Bringing Pod to North Texas As Leaders Take Serious Look at Technology](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
